1 |
고창순 외. 제3판 핵의학. 고려의학 pp247, 2008.
|
2 |
Zhuang H, Pourdehna M, Lambright ES, Yammoto AJ, Lanuti M, Mozley PD, et al. Dual time Point -FDG PET imaging for defferentiating malignant from inflammatory processes J Nucl Med ,Vol. 42, pp.1412-7, 2001.
|
3 |
Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucos metabolism:useful parameter or oversimplification? J Nucl Med, Vol. 35, pp.1308-12, 1994.
|
4 |
Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine induced inflammatory tissue. J Nucl Med 36, 1301-6, 1995.
|
5 |
Irrael O, Yefrmov n, Bar-Shalom R, Kaqana O, Frenkel A. PET/CT detection of unexpected gastrointestinal foci of -FDG uptake: incidence, localization patterns, and clinical signigicance. J Nucl Med 46, pp.758-62, 2005.
|
6 |
Wang Y, Chiu E, Rosenberg J et al Standardized uptake valueatlas: characterization of physiological 2-deoxy-2-[18F]fluoro-D-glucose uptake in normal tissues. Mol Imaging Biol, Vol. 9, pp.83-90, 2007.
DOI
|
7 |
Thie JA. Optimizing dual-time and serial positron emissiontomography and single photon emission computed tomographyscans for diagnoses and therapy monitoring. Mol Imaging Biol, Vol. 9, pp.348-56, 2007.
DOI
ScienceOn
|
8 |
Lodge MA, Lucas JD, Marsden PK, Cronin BF, O'Doherty MJ,Smith MA. A PET study of -FDG uptake in soft tissue masses. Eur J Nucl Med 26, pp.22-30, 1999.
DOI
ScienceOn
|
9 |
PV., Andros, and K.A. Lathrop Argonne; Semi-annual report to the atomic energy comission No. 18, Office of technical services, Department of Commerce, Washington, Vol. 25, D.C., p.7, 1962.
|